<i>IKZF1</i><sup>N159S</sup> is associated with adverse outcomes in patients with myelodysplastic neoplasms
Leukemia, Published online: 14 July 2026; doi:10.1038/s41375-026-03066-2IKZF1N159S is associated with adverse outcomes in patients with myelodysplastic neoplasms
